Informed consent by patients/parents or other legal representatives
You may not be if
Infected wounds or positive general microbiological swabs taken from the nose for multi-resistant germs
Patients tested positive for HBV, HCV, syphilis or HIV
Patients with known underlying or concomitant medical conditions that may interfere with normal wound healing (e.g. immune deficiency, systemic skin diseases, any kind of congenital defect of metabolism including diabetes)
Coagulation disorders as defined by INR outside its normal value, PTT \>ULN and fibrinogen \<LLN and / or at the Investigator's discretion
Previous enrolment of the patient into the current study
Participation of the patient in another study within 30 days preceding and during the present study
Patients or parents/other legal representatives expected not to comply with the study protocol
Suspicion of child abuse
Pregnant or breast feeding females
Contamination derived from biopsy which could interfere with patients health
Due to patient derived variations, isolated cells from biopsy do not proliferate or proliferate insufficiently
Skin substitute has not been released due to production specific deviations
Patients allergic to amphotericin B and gentamicin